The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2 coronavirus, is a global health issue with unprecedented challenges for public health. SARS-CoV-2 primarily infects cells of the respiratory tract, via Spike glycoprotein binding angiotensin-converting enzyme (ACE2). Circadian rhythms coordinate an organism’s response to its environment and can regulate host susceptibility to virus infection. We demonstrate a circadian regulation of ACE2 in lung epithelial cells and show that silencing BMAL1 or treatment with a synthetic REV-ERB agonist SR9009 reduces ACE2 expression and inhibits SARS-CoV-2 entry. Treating infected cells with SR9009 limits viral replication and secretion of infectious particles, showing that post-entry steps in the viral life cycle are influenced by the circadian system. Transcriptome analysis revealed that Bmal1 silencing induced a wide spectrum of interferon stimulated genes in Calu-3 lung epithelial cells, providing a mechanism for the circadian pathway to dampen SARS-CoV-2 infection. Our study suggests new approaches to understand and improve therapeutic targeting of SARS-CoV-2.
Article activity feed
-
SciScore for 10.1101/2021.03.20.436163: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Participants provided written informed consent.
IRB: The study was reviewed by the Oxford Research Ethics Committee B (18/SC/0361).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable C57BL/6J male mice were purchased from Charles River and housed in individually ventilated cages under a 12/12 dark/light cycle with a ZT0 corresponding to 7am. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources After 1h, the cells were washed with PBS before medium containing a VSV-G antibody (I1, mouse hybridoma supernatant from CRL-2700, ATCC) and supernatants harvested after 24h. VSV-Gsuggeste…SciScore for 10.1101/2021.03.20.436163: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Participants provided written informed consent.
IRB: The study was reviewed by the Oxford Research Ethics Committee B (18/SC/0361).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable C57BL/6J male mice were purchased from Charles River and housed in individually ventilated cages under a 12/12 dark/light cycle with a ZT0 corresponding to 7am. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources After 1h, the cells were washed with PBS before medium containing a VSV-G antibody (I1, mouse hybridoma supernatant from CRL-2700, ATCC) and supernatants harvested after 24h. VSV-Gsuggested: NoneI1suggested: NoneMembranes were blocked in 5% milk in PBS/0.1% Tween-20, then incubated with anti-ACE2 (Abcam ab108252), anti-TMPRSS2 (SCBT sc-515727), anti-BMAL1 (Abcam Ab93806) or Anti-β-actin (Sigma A5441) primary antibodies and appropriate HRP-conjugated secondary antibodies (DAKO). anti-ACE2suggested: (Abcam Cat# ab108252, RRID:AB_10864415)anti-TMPRSS2suggested: Noneanti-BMAL1suggested: (Abcam Cat# ab93806, RRID:AB_10675117)Anti-β-actinsuggested: (Sigma-Aldrich Cat# A5441, RRID:AB_476744)Experimental Models: Cell Lines Sentences Resources Cell culture: Calu-3, Huh-7, HEK293T and VERO E6 cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), 2mM L-glutamine, 100 U/mL penicillin and 10μg/mL streptomycin (all reagents from Life Technologies/Thermo Fisher). Huh-7suggested: NoneHEK293Tsuggested: NoneSARS-CoV-2 pseudoparticle genesis and infection: SARS-CoV-2 lentiviral pp were generated by transfecting HEK-293T cells with p8.91 (Gag-pol), pCSFW (luciferase reporter) and a codon optimised expression construct pcDNA3.1-SARS-CoV-2-Spike, as previously reported53. HEK-293Tsuggested: NoneThe VSV*ΔG used for generating the pps was propagated in BHK-21 G43 cells stably expressing VSV-G. BHK-21 G43suggested: NoneViral titres were determined by infecting Calu-3 cells and measuring cellular luciferase after 48h. Calu-3suggested: NoneBriefly, Vero E6 cells were inoculated with serial dilutions of SARS-CoV-2 stocks for 2h followed by addition of a semi-solid overlay consisting of 3% carboxymethyl cellulose (SIGMA). Vero E6suggested: RRID:CVCL_XD71)Experimental Models: Organisms/Strains Sentences Resources C57BL/6J male mice were purchased from Charles River and housed in individually ventilated cages under a 12/12 dark/light cycle with a ZT0 corresponding to 7am. C57BL/6Jsuggested: NoneSoftware and Algorithms Sentences Resources Airway epithelial cells were taken using 2mm diameter cytology brushes from 3rd to 5th order bronchi and cultured in Airway Epithelial Cell medium (PromoCell, Heidelberg, Germany) in submerged culture. PromoCellsuggested: NoneAnti-β-actin-HRP conjugate (Abcam ab49900) and/or Coomassie brilliant blue staining was used to verify equal protein loading and densitometric analysis performed using ImageJ software (NIH). ImageJsuggested: (ImageJ, RRID:SCR_003070)Promoters (−1kb from TSS) of genes encoding SARS-CoV-2 host factors were analyzed with the HOMER (Hypergeometric Optimization of Motif EnRichment) tool for motif discovery (E-box motif CANNTG; RORE motif RGGTCA). HOMERsuggested: (HOMER, RRID:SCR_010881)P values were determined using Mann-Whitney testing (two group comparisons) or with a Kruskal–Wallis ANOVA (multi group comparisons) using PRISM version 9. PRISMsuggested: (PRISM, RRID:SCR_005375)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
